The $12.8 Billion Sleep Disorders Treatment Market
An estimated 70 million Americans have insomnia, and 39 million suffer from obstructive sleep apnea (OSA), mostly undiagnosed. As obesity rates remain high, this problem is not likely to dissipate any time soon. Therefore, there is ample room for...
Aliver
As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. Plus, stressors related to inflation and politics are resulting in more sleepless nights for Americans. Sleep centers had to contend with the pandemic and a shift to less costly at-home tests and declining Medicare reimbursements, but are diversifying their services to add other income streams (such as CPAP fitting, oral appliance therapy, and behavioral sleep medicine). To find out more about the sleep disorders treatment market, check out a new report titled The U.S. Sleep Disorders Treatment Market: Sleep Centers, Sleep Studies & CPAPs by Marketdata LLC. This comprehensive, 97-page report covers market sizing, patient demographics, competitor profiles, regional market potentials, and more. About the Author: John LaRosa is the President of Marketdata LLC and is the author of 100+ industry and market studies. His research appears in top media outlets including ABC, CNN, Fox, Forbes, USA Today, The Wall Street Journal, The New York Times, and a variety of trade journals. 
An estimated 70 million Americans have insomnia, and 39 million suffer from obstructive sleep apnea (OSA), mostly undiagnosed. As obesity rates remain high, this problem is not likely to dissipate any time soon. Therefore, there is ample room for future growth of CPAP devices and sleep studies, performed at home or in specialized clinics.Top 6 Things to Know About the Sleep Centers & CPAPs Market
Market size and growth: Marketdata estimates that the U.S. sleep centers market was worth $7.75 billion in 2023, while the CPAPs devices market is worth $5.06 billion. The CPAPs market is growing faster.
Demand: 50-70 million U.S. adults have a sleep disorder, with 39 million of them having sleep apnea.
Industry structure: The sleep centers market is fragmented and is populated by more than 4,500 small, privately owned operations, while the CPAPs market is dominated by two large healthcare companies: ResMed and Respironics (Philips).
Sleep centers: This market is a mature, low-growth, low-profit market populated by small, private companies with average gross annual revenues of $1.7 million.
Competition: Marketdata analysts estimate that the true number of sleep centers in the U.S. is about 4,560. The total estimated number of ACCREDITED sleep centers is at least 3,256.
Trends: Pre-COVID volumes were 70% in-lab and 30% home sleep testing (HST), according to various surveys, which found this in-lab to home testing ratio flipped during the pandemic. It’s now 70% home tests and 30% in-center tests.
Where to Learn More
